Mark B. Nienhuis

778 citations

17 papers · 554 indexed · h-index 12

Cardiology and Cardiovascular Medicine top 5%
Surgery top 10%
Radiology, Nuclear Medicine and Imaging top 5%
Pulmonary and Respiratory Medicine
Neurology

Co-authors: Jan Paul Ottervanger Felix Zijlstra Bert D. Dikkeschei Henk J.G. Bilo Mounir W.Z. Basalus Martin G. Stoel Clemens von Birgelen Gerard C.M. Linssen
Topics: Coronary Interventions and Diagnostics (14 papers)Acute Myocardial Infarction Research (8 papers)Cardiac Imaging and Diagnostics (6 papers)
Cited by: Cardiology and Cardiovascular Medicine Radiology, Nuclear Medicine and Imaging Surgery
Journals: The Lancet Journal of the American College of Cardiology The American Journal of Cardiology
Partner nations: Netherlands Greece United States

In The Last Decade

Mark B. Nienhuis

17 papers receiving 546 citations

Peers

Countries citing papers authored by Mark B. Nienhuis

Since Specialization

Citations

This map shows the geographic impact of Mark B. Nienhuis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Nienhuis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Nienhuis more than expected).

Fields of papers citing papers by Mark B. Nienhuis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark B. Nienhuis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Nienhuis. The network helps show where Mark B. Nienhuis may publish in the future.

Co-authorship network of co-authors of Mark B. Nienhuis

This figure shows the co-authorship network connecting the top 25 collaborators of Mark B. Nienhuis. A scholar is included among the top collaborators of Mark B. Nienhuis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark B. Nienhuis. Mark B. Nienhuis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial 2015 ·EuroIntervention ·Ming Kai Lam,Kenneth Tandjung,Hanim Sen,Mounir W.Z. Basalus,K. Gert van Houwelingen,Martin G. Stoel,J. W. Louwerenburg,Gerard C.M. Linssen,Salah AM Said,Mark B. Nienhuis,Frits H.A.F. de Man,Job van der Palen,Clemens von Birgelen	14
2	Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial 2014 ·EuroIntervention ·Hanim Sen,Ming Kai Lam,Kenneth Tandjung,Mounir W.Z. Basalus,Frits H.A.F. de Man,(unknown),Martin G. Stoel,Gert K. van Houwelingen,Marije M. Löwik,Gerard C.M. Linssen,Salah AM Said,Mark B. Nienhuis,Patrick M.J. Verhorst,Job van der Palen,Clemens von Birgelen	3
3	Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents 2013 ·Journal of the American College of Cardiology ·Kenneth Tandjung,Hanim Sen,Ming Kai Lam,Mounir W.Z. Basalus,J. W. Louwerenburg,Martin G. Stoel,K. Gert van Houwelingen,Frits H.A.F. de Man,Gerard C.M. Linssen,Salah AM Said,Mark B. Nienhuis,Marije M. Löwik,Patrick M.J. Verhorst,Job van der Palen,Clemens von Birgelen	56
4	Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial 2013 ·The Lancet ·Clemens von Birgelen,Hanim Sen,Ming Kai Lam,Peter W. Danse,Gillian A.J. Jessurun,Raymond W.M. Hautvast,Gert K. van Houwelingen,Alexander Schramm,Melvyn Tjon Joe Gin,J. W. Louwerenburg,Frits H.A.F. de Man,Martin G. Stoel,Marije M. Löwik,Gerard C.M. Linssen,Salah AM Said,Mark B. Nienhuis,Patrick M.J. Verhorst,Mounir W.Z. Basalus,Carine J.M. Doggen,Kenneth Tandjung	140
5	TCT-47 Two-Year Clinical Outcome of the TWENTE Trial, a Randomized Controlled Trial Comparing Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients 2012 ·Journal of the American College of Cardiology ·Clemens von Birgelen,Kenneth Tandjung,Hanim Sen,Mounir W.Z. Basalus,(unknown),Martin G. Stoel,K. Gert van Houwelingen,Gerard C.M. Linssen,Salah AM Said,Mark B. Nienhuis,Marije M. Löwik,Job van der Palen,Patrick M.J. Verhorst,(unknown)	4
6	Comparison of Frequency of Periprocedural Myocardial Infarction in Patients With and Without Diabetes Mellitus to Those With Previously Unknown but Elevated Glycated Hemoglobin Levels (from the TWENTE Trial) 2012 ·The American Journal of Cardiology ·Kenneth Tandjung,K. Gert van Houwelingen,Hanneke Jansen,Mounir W.Z. Basalus,Hanim Sen,Marije M. Löwik,Martin G. Stoel,J. W. Louwerenburg,Frits H.A.F. de Man,Gerard C.M. Linssen,(unknown),Mark B. Nienhuis,Job van der Palen,Ronald P. Stolk,Clemens von Birgelen	22
7	Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and XIENCE V drug-eluting stents 2012 ·EuroIntervention ·Hanim Sen,Kenneth Tandjung,Mounir W.Z. Basalus,Marije M. Löwik,Gert K. van Houwelingen,Martin G. Stoel,Hans W. Louwerenburg,Frits H.A.F. de Man,Gerard C.M. Linssen,(unknown),Mark B. Nienhuis,Patrick M.J. Verhorst,Job van der Palen,Clemens von Birgelen	16
8	DUrable polymer-based sTent CHallenge of Promus ElemEnt versus ReSolute integrity (DUTCH PEERS): Rationale and study design of a randomized multicenter trial in a Dutch all-comers population 2012 ·American Heart Journal ·Kenneth Tandjung,Mounir W.Z. Basalus,Hanim Sen,Gillian A.J. Jessurun,Peter W. Danse,Martin G. Stoel,Gerard C.M. Linssen,(unknown),(unknown),Mark B. Nienhuis,Raymond W.M. Hautvast,Clemens von Birgelen	17
9	Incidence of periprocedural myocardial infarction following stent implantation: Comparison between first‐ and second‐generation drug‐eluting stents 2011 ·Catheterization and Cardiovascular Interventions ·Kenneth Tandjung,Mounir W.Z. Basalus,(unknown),Hans W. Louwerenburg,K. Gert van Houwelingen,Martin G. Stoel,Frits H.A.F. de Man,Hanneke Jansen,(unknown),Gerard C.M. Linssen,(unknown),Mark B. Nienhuis,Clemens von Birgelen	8
10	Detection of fibrillations using muscle ultrasound: Diagnostic accuracy and identification of pitfalls 2011 ·Muscle & Nerve ·Nens van Alfen,Mark B. Nienhuis,Machiel J. Zwarts,Sigrid Pillen	15
11	Muscles alive: Ultrasound detects fibrillations 2009 ·Clinical Neurophysiology ·Sigrid Pillen,Mark B. Nienhuis,Johannes van Dijk,Ilse M.P. Arts,Nens van Alfen,Machiel J. Zwarts	27
12	Prognostic value of troponin after elective percutaneous coronary intervention: A meta‐analysis 2008 ·Catheterization and Cardiovascular Interventions ·Mark B. Nienhuis,Jan Paul Ottervanger,Henk J.G. Bilo,Bert D. Dikkeschei,Felix Zijlstra	134
13	Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction 2008 ·Coronary Artery Disease ·Mark B. Nienhuis,Jan Paul Ottervanger,Jan‐Henk E. Dambrink,Menko‐Jan de Boer,Jan C.A. Hoorntje,(unknown),Harry Suryapranata,Arnoud W.J. van ‘t Hof	24
14	Prognostic importance of creatine kinase and creatine kinase–MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction 2008 ·American Heart Journal ·Mark B. Nienhuis,Jan Paul Ottervanger,Menko‐Jan de Boer,Jan‐Henk E. Dambrink,Jan C.A. Hoorntje,A.T. Marcel Gosselink,Harry Suryapranata,Arnoud W.J. van ‘t Hof	40
15	Pre-treatment with clopidogrel and postprocedure troponin elevation after elective percutaneous coronary intervention 2006 ·Thrombosis and Haemostasis ·Mark B. Nienhuis,Kor Miedema,Harry Suryapranata,Menko‐Jan de Boer,Jan–Henk Dambrink,(unknown),Arnoud W.J. van ‘t Hof,M. Gosselink,(unknown),Jan Paul Ottervanger	7
16	Prognostic importance of troponin T and creatine kinase after elective angioplasty 2006 ·International Journal of Cardiology ·Mark B. Nienhuis,Jan Paul Ottervanger,Bert D. Dikkeschei,Harry Suryapranata,Menko‐Jan de Boer,Jan‐Henk E. Dambrink,Jan C.A. Hoorntje,Arnoud W.J. van ‘t Hof,M. Gosselink,Felix Zijlstra	19
17	Predictors of elevated cardiac troponin T on admission in ST-segment elevation myocardial infarction 2006 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·Saman Rasoul,Mark B. Nienhuis,Jan Paul Ottervanger,Robbert J. Slingerland,Menko‐Jan de Boer,Jan‐Henk E. Dambrink,Nicolette Ernst,Jan C.A. Hoorntje,A.T. Marcel Gosselink,Harry Suryapranata,Felix Zijlstra,Arnoud W.J. van ‘t Hof	8

About Mark B. Nienhuis

Mark B. Nienhuis is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 17 papers that have together received 554 indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (14 papers), Acute Myocardial Infarction Research (8 papers) and Cardiac Imaging and Diagnostics (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (433 citations), Radiology, Nuclear Medicine and Imaging (239 citations) and Surgery (391 citations). Mark B. Nienhuis has collaborated with scholars based in Netherlands, Greece and United States. Frequent co-authors include Jan Paul Ottervanger, Felix Zijlstra, Bert D. Dikkeschei, Henk J.G. Bilo, Mounir W.Z. Basalus, Martin G. Stoel, Clemens von Birgelen, Gerard C.M. Linssen, Kenneth Tandjung and Hanim Sen. Their work appears in journals such as The Lancet, Journal of the American College of Cardiology and The American Journal of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact